Back to User profile » Dr Faustine Luo
Papers published by Dr Faustine Luo:
Commentary
LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154)
Luo FX, Arter Z, Ou SI, Nagasaka M
Lung Cancer: Targets and Therapy 2025, 16:51-55
Published Date: 25 April 2025
Commentary
Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma
Luo FX, Arter ZL
Lung Cancer: Targets and Therapy 2024, 15:161-167
Published Date: 30 October 2024
Commentary
“ACHILLES” Heel No More? Afatinib at 40 Mg Once Daily is Superior to Platinum-Based Chemotherapy in EGFR Uncommon (G719X, S768I, and L861Q) Mutations (ACHILLES/TORG1834)
Luo FX, Ou SI
Lung Cancer: Targets and Therapy 2024, 15:69-73
Published Date: 18 May 2024